Skip to main content
NCBI home page
Clinical and Experimental Immunology logoLink to Clinical and Experimental Immunology
. 1995 Nov;102(2):286–289. doi: 10.1111/j.1365-2249.1995.tb03779.x

Alterations in interleukin secretion (IL-2 and IL-4) by CD4 and CD4 CD45RO cells from common variable immunodeficiency (CVI) patients.

J M Ferrer 1, J Iglesias 1, M Hernández 1, N Matamoros 1
PMCID: PMC1553419  PMID: 7586680

Abstract

The failure of B cells from CVI patients to secrete normal amounts of antibodies has been attributed either to an intrinsic B cell defect or to a lack of cooperation from T cells. In an attempt to improve the definition of the origin of this defect in one of the main cellular compartments, we studied the ability of helper CD4 cells and their CD4 CD45RO subpopulation from CVI patients to secrete interleukins (IL-2 and IL-4) in response to mitogen stimulation. We found that CD4 and CD4 CD45RO cells from some patients secrete abnormal amounts of interleukins (in general low levels of IL-2 and high levels of IL-4) upon stimulation with pokeweed mitogen (PWM). These irregularities may contribute to the defective differentiation of B cells in these patients.

Full text

PDF
286

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bergstedt-Lindqvist S., Moon H. B., Persson U., Möller G., Heusser C., Severinson E. Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur J Immunol. 1988 Jul;18(7):1073–1077. doi: 10.1002/eji.1830180716. [DOI] [PubMed] [Google Scholar]
  2. Bryant A., Calver N. C., Toubi E., Webster A. D., Farrant J. Classification of patients with common variable immunodeficiency by B cell secretion of IgM and IgG in response to anti-IgM and interleukin-2. Clin Immunol Immunopathol. 1990 Aug;56(2):239–248. doi: 10.1016/0090-1229(90)90145-g. [DOI] [PubMed] [Google Scholar]
  3. Farrant J., Bryant A., Almandoz F., Spickett G., Evans S. W., Webster A. D. B cell function in acquired "common-variable" hypogammaglobulinemia: proliferative responses to lymphokines. Clin Immunol Immunopathol. 1989 May;51(2):196–204. doi: 10.1016/0090-1229(89)90019-6. [DOI] [PubMed] [Google Scholar]
  4. Farrant J., Spickett G., Matamoros N., Copas D., Hernandez M., North M., Chapel H., Webster A. D. Study of B and T cell phenotypes in blood from patients with common variable immunodeficiency (CVID). Immunodeficiency. 1994;5(2):159–169. [PubMed] [Google Scholar]
  5. Farrington M., Grosmaire L. S., Nonoyama S., Fischer S. H., Hollenbaugh D., Ledbetter J. A., Noelle R. J., Aruffo A., Ochs H. D. CD40 ligand expression is defective in a subset of patients with common variable immunodeficiency. Proc Natl Acad Sci U S A. 1994 Feb 1;91(3):1099–1103. doi: 10.1073/pnas.91.3.1099. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Ferrer J. M., Plaza A., Kreisler M., Díaz-Espada F. Differential interleukin secretion by in vitro activated human CD45RA and CD45RO CD4+ T cell subsets. Cell Immunol. 1992 Apr 15;141(1):10–20. doi: 10.1016/0008-8749(92)90123-7. [DOI] [PubMed] [Google Scholar]
  7. Llorente L., Crevon M. C., Karray S., Defrance T., Banchereau J., Galanaud P. Interleukin (IL) 4 counteracts the helper effect of IL2 on antigen-activated human B cells. Eur J Immunol. 1989 Apr;19(4):765–769. doi: 10.1002/eji.1830190429. [DOI] [PubMed] [Google Scholar]
  8. Pastorelli G., Roncarolo M. G., Touraine J. L., Peronne G., Tovo P. A., de Vries J. E. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens. Clin Exp Immunol. 1989 Dec;78(3):334–340. [PMC free article] [PubMed] [Google Scholar]
  9. Sneller M. C., Strober W. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency. J Immunol. 1990 May 15;144(10):3762–3769. [PubMed] [Google Scholar]
  10. Spickett G. P., Matamoros N., Farrant J. Lymphocyte surface phenotype in common variable immunodeficiency. Dis Markers. 1992 Mar-Apr;10(2):67–80. [PubMed] [Google Scholar]
  11. Spickett G. P., Webster A. D., Farrant J. Cellular abnormalities in common variable immunodeficiency. Immunodefic Rev. 1990;2(3):199–219. [PubMed] [Google Scholar]
  12. Splawski J. B., McAnally L. M., Lipsky P. E. IL-2 dependence of the promotion of human B cell differentiation by IL-6 (BSF-2). J Immunol. 1990 Jan 15;144(2):562–569. [PubMed] [Google Scholar]
  13. Swain S. L., McKenzie D. T., Weinberg A. D., Hancock W. Characterization of T helper 1 and 2 cell subsets in normal mice. Helper T cells responsible for IL-4 and IL-5 production are present as precursors that require priming before they develop into lymphokine-secreting cells. J Immunol. 1988 Nov 15;141(10):3445–3455. [PubMed] [Google Scholar]
  14. Zielen S., Bauscher P., Hofmann D., Meuer S. C. Interleukin 10 and immune restoration in common variable immunodeficiency. Lancet. 1993 Sep 18;342(8873):750–751. [PubMed] [Google Scholar]
  15. de la Calle-Martín O., Alberola-Ila J., Engel P., Inglés J., Fabregat V., Barceló J. J., Lozano F., Gallart T. Impaired post-transcriptional expression of interleukin-2 receptor in pokeweed mitogen-activated T cells. Eur J Immunol. 1992 Apr;22(4):897–902. doi: 10.1002/eji.1830220403. [DOI] [PubMed] [Google Scholar]

Articles from Clinical and Experimental Immunology are provided here courtesy of British Society for Immunology

RESOURCES